Mechanical Ventilation Modes for Preventing Muscle Wasting
Trial Summary
What is the purpose of this trial?
The objective of the study is to determine how controlled mode ventilation and support mode ventilation impact ventilator-free days and diaphragmatic atrophy.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Assist Control Mode Mechanical Ventilation and its related modes?
Is mechanical ventilation safe for humans?
Mechanical ventilation modes like Pressure Regulated Volume Control (PRVC) and Volume-Controlled Continuous Mandatory Ventilation (VC-CMV) are generally used in intensive care settings and have been studied for safety. While PRVC can lower peak airway pressures, it may sometimes lead to issues like patient-ventilator dyssynchrony (when the machine and patient are not in sync). Overall, these modes are commonly used and considered safe, but they require careful monitoring by healthcare professionals.12346
How does Assist Control Mode Mechanical Ventilation differ from other treatments for preventing muscle wasting?
Assist Control Mode Mechanical Ventilation is unique because it provides positive pressure assistance based on the patient's own breathing efforts, which helps prevent muscle wasting by minimizing disuse atrophy of the respiratory muscles. This mode can also facilitate the weaning process and usually requires lower ventilator pressures compared to other modes.178910
Research Team
Bhakti Patel, MD
Principal Investigator
University of Chicago
John P Kress, MD
Principal Investigator
University of Chicago
Roger Struble, MD
Principal Investigator
University of Iowa
Eligibility Criteria
This trial is for adults over 18 who've been on a mechanical ventilator for less than 36 hours. It's not suitable for those with recent cardiac arrest, high spinal injuries, past ventilation within six months, pregnancy, muscle paralysis drugs in use, diaphragm issues or neuromuscular diseases, tracheostomies, expected quick weaning from the ventilator or severe COPD/asthma.Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized to either volume support mode or assist control mode ventilation, with diaphragm thickness measured daily by ultrasound
Follow-up
Participants are monitored for safety and effectiveness after treatment, including discharge destination and mortality
Treatment Details
Interventions
- Assist Control Mode Mechanical Ventilation
- Volume Support Mode Mechanical Ventilation
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Chicago
Lead Sponsor